Regulator of G protein signalling 6 (RGS6) inhibits the formation of complexes between SMAD4 and SMAD2/3 by binding to SMAD4, inhibiting the TGF-β pathway and thus inhibiting EMT in NSCLC [108]. Here, RGS6 is linked to non-small cell lung carcinoma.